Source: Resumos. Conference titles: Congresso Brasileiro de Farmacologia e Terapêutica Experimental. Unidade: ICB
Assunto: FARMACOLOGIA
ABNT
HERRERA, B. S. et al. iNOS-derived nitric oxide modulates bone loss from ligature induced periodontitis by inhibiting osteoclast differentiation and activity. 2010, Anais.. Ribeirão Preto: Sociedade Brasileira de Farmacologia e Terapêutica Experimental - SBFTE, 2010. . Acesso em: 30 ago. 2024.APA
Herrera, B. S., Martins Porto, R., Costa, S. K. P., Spolidório, L. C., Van Dyke, T. E., Gyurko, R., & Muscará, M. N. (2010). iNOS-derived nitric oxide modulates bone loss from ligature induced periodontitis by inhibiting osteoclast differentiation and activity. In Resumos. Ribeirão Preto: Sociedade Brasileira de Farmacologia e Terapêutica Experimental - SBFTE.NLM
Herrera BS, Martins Porto R, Costa SKP, Spolidório LC, Van Dyke TE, Gyurko R, Muscará MN. iNOS-derived nitric oxide modulates bone loss from ligature induced periodontitis by inhibiting osteoclast differentiation and activity. Resumos. 2010 ;[citado 2024 ago. 30 ]Vancouver
Herrera BS, Martins Porto R, Costa SKP, Spolidório LC, Van Dyke TE, Gyurko R, Muscará MN. iNOS-derived nitric oxide modulates bone loss from ligature induced periodontitis by inhibiting osteoclast differentiation and activity. Resumos. 2010 ;[citado 2024 ago. 30 ]